Literature DB >> 16815786

Cytokine responses to resistance training in people with multiple sclerosis.

Lesley J White1, Vanessa Castellano, Sean C Mc Coy.   

Abstract

Exercise for individuals with multiple sclerosis (MS) has been shown to improve cardiovascular function, increase strength and endurance, and reduce fatigue. The impact of exercise on immune function in the disease, however, remains mostly unexplored. Ten female MS patients participated in an 8 week programme of twice-weekly progressive resistance training, with pre- and post-training assessment of serum concentrations of cytokines IL-2, IL-4, IL-6, IL-10, CRP, TNF-alpha and IFN-gamma. After training, IL-4, IL-10, CRP and IFN-gamma showed statistically reduced resting concentrations in blood, while TNF-alpha showed non-significant reductions and IL-2 and IL-6 remained unchanged. These results suggest that progressive resistance training may have an impact on cytokine concentrations in individuals with MS and should be confirmed in studies with stronger statistical power. The impact of these changes on overall immune function in MS and on disease status and prognosis remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16815786     DOI: 10.1080/02640410500357036

Source DB:  PubMed          Journal:  J Sports Sci        ISSN: 0264-0414            Impact factor:   3.337


  19 in total

1.  Effect of aerobic interval training on serum IL-10, TNFα, and adipokines levels in women with multiple sclerosis: possible relations with fatigue and quality of life.

Authors:  Motahare Mokhtarzade; Rouholah Ranjbar; Nastaran Majdinasab; Darpan Patel; Mehdieh Molanouri Shamsi
Journal:  Endocrine       Date:  2017-06-14       Impact factor: 3.633

2.  Exercise and disease progression in multiple sclerosis: can exercise slow down the progression of multiple sclerosis?

Authors:  Ulrik Dalgas; Egon Stenager
Journal:  Ther Adv Neurol Disord       Date:  2012-03       Impact factor: 6.570

Review 3.  The benefits of exercise training in multiple sclerosis.

Authors:  Robert W Motl; Lara A Pilutti
Journal:  Nat Rev Neurol       Date:  2012-07-24       Impact factor: 42.937

4.  Effect of resistance training during hemodialysis on circulating cytokines: a randomized controlled trial.

Authors:  Birinder Singh Bobby Cheema; Haifa Abas; Benjamin C F Smith; Anthony J O'Sullivan; Maria Chan; Aditi Patwardhan; John Kelly; Adrian Gillin; Glen Pang; Brad Lloyd; Klaus Berger; Bernhard T Baune; Maria A Fiatarone Singh
Journal:  Eur J Appl Physiol       Date:  2010-12-16       Impact factor: 3.078

Review 5.  Endocrine responses of the stress system to different types of exercise.

Authors:  Nikolaos Athanasiou; Gregory C Bogdanis; George Mastorakos
Journal:  Rev Endocr Metab Disord       Date:  2022-10-15       Impact factor: 9.306

6.  Cytokine Profile in Patients with Multiple Sclerosis Following Exercise: A Systematic Review of Randomized Clinical Trials.

Authors:  Parisa Najafi; Maryam Hadizadeh; Jadeera Phaik Geok Cheong; Hamidreza Mohafez; Suhailah Abdullah
Journal:  Int J Environ Res Public Health       Date:  2022-07-02       Impact factor: 4.614

7.  Exercise but not diet-induced weight loss decreases skeletal muscle inflammatory gene expression in frail obese elderly persons.

Authors:  Charles P Lambert; Nicole R Wright; Brian N Finck; Dennis T Villareal
Journal:  J Appl Physiol (1985)       Date:  2008-06-05

Review 8.  Role of exercise on visceral adiposity after spinal cord injury: a cardiometabolic risk factor.

Authors:  Jacob A Goldsmith; Areej N Ennasr; Gary J Farkas; David R Gater; Ashraf S Gorgey
Journal:  Eur J Appl Physiol       Date:  2021-04-23       Impact factor: 3.078

9.  The impact of regular physical activity on fatigue, depression and quality of life in persons with multiple sclerosis.

Authors:  Nicole M Stroud; Clare L Minahan
Journal:  Health Qual Life Outcomes       Date:  2009-07-20       Impact factor: 3.186

10.  Getting the balance right: a randomised controlled trial of physiotherapy and Exercise Interventions for ambulatory people with multiple sclerosis.

Authors:  Susan Coote; Maria Garrett; Neasa Hogan; Aidan Larkin; Jean Saunders
Journal:  BMC Neurol       Date:  2009-07-16       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.